A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Woebot Health Names Matt Borowiecki Chief Financial Officer

What To Know

  • A member of the senior management team, Borowiecki will lead the company's financial operations and strategy, including management and financial reporting, budgeting and long-term financial planning, and will also manage its capital structure.
  • Borowiecki holds a Master of Business Administration degree from the Tuck School of Business at Dartmouth and a Bachelor of Arts degree in Economics from Kenyon College.

Woebot Health today announced that it has appointed Matt Borowiecki as its Chief Financial Officer. A member of the senior management team, Borowiecki will lead the company’s financial operations and strategy, including management and financial reporting, budgeting and long-term financial planning, and will also manage its capital structure. He reports to Chief Executive Officer Michael Evers.

Matt Borowiecki has more than 20 years of global experience in finance, strategy and corporate development across healthcare, insurance and financial services, and has managed acquisitions, divestitures, joint ventures and debt and equity financings totaling more than $60 billion of value. Before joining Woebot Health, Borowiecki was the Chief Financial Officer at Biofourmis, a technology-enabled care delivery and digital therapeutics company. In that position, he led Biofourmis’ financial operations as it scaled revenue, customers and employees and surpassed unicorn status.

Before that, Borowiecki was the Head of Capital Transactions and Structuring at MassMutual Financial Group. His healthcare industry experience dates to 2011 when he joined Aetna as its Director of Corporate Development and Enterprise Strategic Planning. Previously Borowiecki held positions of increasing responsibility at leading investment banks Morgan Stanley, Lehman Brothers and UBS.

“Matt’s deep understanding of the healthcare industry and investment acumen will be instrumental as we mature our operations and move to the next level of our company’s growth,” said Evers. “His strategic experience is complemented by a deep compassion and commitment to helping people access the mental health care they need. We’re delighted he’s joined at this very pivotal moment.”

“The last few years have placed a spotlight on mental health, while the last few months have seen incredible advances in technologies that can play a role in changing the way we deliver care,” said Borowiecki. “We have the opportunity to really make a difference in patients’ lives, and that’s extremely motivating.”

Borowiecki holds a Master of Business Administration degree from the Tuck School of Business at Dartmouth and a Bachelor of Arts degree in Economics from Kenyon College. He is an avid traveler who has visited 47 countries and dependencies and 44 U.S. states.

Other Executives In the News

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

“Adding Michael to the Avation leadership team is our next step in launching Vivally,” said Jill Schiaparelli, founder and CEO of Avation Medical. “Patients have been crystal clear that they want a surgical-free, non-invasive treatment option for their OAB symptoms. Our focus now is to ensure that Vivally is easily accessible to the 46 million patients suffering from OAB in this country.”
Dennis has an extraordinary depth of knowledge and is highly respected in the obesity field; I could not imagine anyone more perfect to lead our company,” said Jeff Arnold, Chairman and a Director at Xeno Biosciences since 2017.
Peter Eckes offers more than a 30-year career in the agricultural industry, and provides a unique appreciation for what it takes to bring innovation to the modern agriculture marketplace at scale without losing sight of farmer and consumer needs.

By using this website you agree to accept Medical Device News Magazine Privacy Policy